Literature DB >> 28837163

A 31-residue peptide induces aggregation of tau's microtubule-binding region in cells.

Jan Stöhr1,2, Haifan Wu3, Mimi Nick3, Yibing Wu3, Manasi Bhate3, Carlo Condello1,2, Noah Johnson1, Jeffrey Rodgers4, Thomas Lemmin3, Srabasti Acharya1, Julia Becker1, Kathleen Robinson1, Mark J S Kelly3, Feng Gai4, Gerald Stubbs5, Stanley B Prusiner1,2,6, William F DeGrado1,3.   

Abstract

The self-propagation of misfolded conformations of tau underlies neurodegenerative diseases, including Alzheimer's. There is considerable interest in discovering the minimal sequence and active conformational nucleus that defines this self-propagating event. The microtubule-binding region, spanning residues 244-372, reproduces much of the aggregation behaviour of tau in cells and animal models. Further dissection of the amyloid-forming region to a hexapeptide from the third microtubule-binding repeat resulted in a peptide that rapidly forms fibrils in vitro. We show that this peptide lacks the ability to seed aggregation of tau244-372 in cells. However, as the hexapeptide is gradually extended to 31 residues, the peptides aggregate more slowly and gain potent activity to induce aggregation of tau244-372 in cells. X-ray fibre diffraction, hydrogen-deuterium exchange and solid-state NMR studies map the beta-forming region to a 25-residue sequence. Thus, the nucleus for self-propagating aggregation of tau244-372 in cells is packaged in a remarkably small peptide.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28837163      PMCID: PMC5759337          DOI: 10.1038/nchem.2754

Source DB:  PubMed          Journal:  Nat Chem        ISSN: 1755-4330            Impact factor:   24.427


  40 in total

1.  Cell biology. A unifying role for prions in neurodegenerative diseases.

Authors:  Stanley B Prusiner
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

2.  The common architecture of cross-beta amyloid.

Authors:  Thomas R Jahn; O Sumner Makin; Kyle L Morris; Karen E Marshall; Pei Tian; Pawel Sikorski; Louise C Serpell
Journal:  J Mol Biol       Date:  2009-09-23       Impact factor: 5.469

3.  Natural and synthetic prion structure from X-ray fiber diffraction.

Authors:  Holger Wille; Wen Bian; Michele McDonald; Amy Kendall; David W Colby; Lillian Bloch; Julian Ollesch; Alexander L Borovinskiy; Fred E Cohen; Stanley B Prusiner; Gerald Stubbs
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-28       Impact factor: 11.205

4.  Fungal prion HET-s as a model for structural complexity and self-propagation in prions.

Authors:  William Wan; Gerald Stubbs
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

5.  Correlation of structural elements and infectivity of the HET-s prion.

Authors:  Christiane Ritter; Marie-Lise Maddelein; Ansgar B Siemer; Thorsten Lührs; Matthias Ernst; Beat H Meier; Sven J Saupe; Roland Riek
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 6.  Prion diseases.

Authors:  Leonel T Takada; Michael D Geschwind
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

7.  Use of a benzimidazole derivative BF-188 in fluorescence multispectral imaging for selective visualization of tau protein fibrils in the Alzheimer's disease brain.

Authors:  Ryuichi Harada; Nobuyuki Okamura; Shozo Furumoto; Takeo Yoshikawa; Hiroyuki Arai; Kazuhiko Yanai; Yukitsuka Kudo
Journal:  Mol Imaging Biol       Date:  2014-02       Impact factor: 3.488

8.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

Review 9.  Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.

Authors:  Michel Goedert; Ben Falcon; Florence Clavaguera; Markus Tolnay
Journal:  Curr Neurol Neurosci Rep       Date:  2014-11       Impact factor: 5.081

10.  Distinct tau prion strains propagate in cells and mice and define different tauopathies.

Authors:  David W Sanders; Sarah K Kaufman; Sarah L DeVos; Apurwa M Sharma; Hilda Mirbaha; Aimin Li; Scarlett J Barker; Alex C Foley; Julian R Thorpe; Louise C Serpell; Timothy M Miller; Lea T Grinberg; William W Seeley; Marc I Diamond
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

View more
  18 in total

1.  In vitro 0N4R tau fibrils contain a monomorphic β-sheet core enclosed by dynamically heterogeneous fuzzy coat segments.

Authors:  Aurelio J Dregni; Venkata S Mandala; Haifan Wu; Matthew R Elkins; Harrison K Wang; Ivan Hung; William F DeGrado; Mei Hong
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-29       Impact factor: 11.205

2.  Compromised function of the ESCRT pathway promotes endolysosomal escape of tau seeds and propagation of tau aggregation.

Authors:  John J Chen; Diane L Nathaniel; Preethi Raghavan; Maxine Nelson; Ruilin Tian; Eric Tse; Jason Y Hong; Stephanie K See; Sue-Ann Mok; Marco Y Hein; Daniel R Southworth; Lea T Grinberg; Jason E Gestwicki; Manuel D Leonetti; Martin Kampmann
Journal:  J Biol Chem       Date:  2019-10-02       Impact factor: 5.157

3.  Role of the Disulfide Bond in Prion Protein Amyloid Formation: A Thermodynamic and Kinetic Analysis.

Authors:  Ryo Honda
Journal:  Biophys J       Date:  2018-02-27       Impact factor: 4.033

Review 4.  Elucidating Tau function and dysfunction in the era of cryo-EM.

Authors:  Guy Lippens; Benoît Gigant
Journal:  J Biol Chem       Date:  2019-05-14       Impact factor: 5.157

5.  Glutamine Side Chain 13C═18O as a Nonperturbative IR Probe of Amyloid Fibril Hydration and Assembly.

Authors:  Haifan Wu; Daniel J Saltzberg; Huong T Kratochvil; Hyunil Jo; Andrej Sali; William F DeGrado
Journal:  J Am Chem Soc       Date:  2019-04-24       Impact factor: 15.419

6.  Effects of All-Atom Molecular Mechanics Force Fields on Amyloid Peptide Assembly: The Case of PHF6 Peptide of Tau Protein.

Authors:  Viet Hoang Man; Xibing He; Jie Gao; Junmei Wang
Journal:  J Chem Theory Comput       Date:  2021-09-07       Impact factor: 6.006

Review 7.  Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.

Authors:  Juan Carlos Polanco; Chuanzhou Li; Liviu-Gabriel Bodea; Ramon Martinez-Marmol; Frederic A Meunier; Jürgen Götz
Journal:  Nat Rev Neurol       Date:  2017-12-15       Impact factor: 42.937

Review 8.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

Review 9.  The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Aggregates.

Authors:  Benjamin C Creekmore; Yi-Wei Chang; Edward B Lee
Journal:  J Neuropathol Exp Neurol       Date:  2021-06-04       Impact factor: 3.148

10.  Inclusion of the C-Terminal Domain in the β-Sheet Core of Heparin-Fibrillized Three-Repeat Tau Protein Revealed by Solid-State Nuclear Magnetic Resonance Spectroscopy.

Authors:  Aurelio J Dregni; Harrison K Wang; Haifan Wu; Pu Duan; Jia Jin; William F DeGrado; Mei Hong
Journal:  J Am Chem Soc       Date:  2021-05-13       Impact factor: 16.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.